Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 3 Primary Myelofibrosis 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Hodgkin Disease 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Biphenotypic, Acute 1 Kidney Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1

Interventions

Injections 6 Fluorodeoxyglucose F18 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 fludarabine 2 Specimen Handling 2 Nivolumab 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 trametinib 1 tislelizumab 1 temsirolimus 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 etoposide phosphate 1 enzalutamide 1 envafolimab 1 donafenib 1 disitamab vedotin 1 dabrafenib 1 cemiplimab 1 avelumab 1 atezolizumab 1 anlotinib 1 WW Domain-Containing Oxidoreductase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor × Blood Component Removal × Clear all

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡